2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine

C114H104Cl2FN17O5 — CID 159600688

IUPAC2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine
SMILESCOCc1c(-c2ccc(Cl)cc2)nc2ccc(-c3ccccc3)cn12.Clc1ccc(-c2nc3cnc(-c4ccccc4)cn3c2CN2CCOCC2)cc1.Fc1ccc(-c2nc3ccc(-c4ccccc4)cn3c2CN2CCOCC2)cc1.c1ccc(-c2ccc3nc(-c4ccccn4)c(CN4CCOCC4)n3c2)cc1.c1ccc(-c2ccc3nc(-c4ccncc4)c(CN4CCOCC4)n3c2)cc1
InChIInChI=1S/C24H22FN3O.C23H21ClN4O.2C23H22N4O.C21H17ClN2O/c25-21-9-6-19(7-10-21)24-22(17-27-12-14-29-15-13-27)28-16-20(8-11-23(28)26-24)18-4-2-1-3-5-18;24-19-8-6-18(7-9-19)23-21(16-27-10-12-29-13-11-27)28-15-20(25-14-22(28)26-23)17-4-2-1-3-5-17;1-2-6-18(7-3-1)19-9-10-22-25-23(20-8-4-5-11-24-20)21(27(22)16-19)17-26-12-14-28-15-13-26;1-2-4-18(5-3-1)20-6-7-22-25-23(19-8-10-24-11-9-19)21(27(22)16-20)17-26-12-14-28-15-13-26;1-25-14-19-21(16-7-10-18(22)11-8-16)23-20-12-9-17(13-24(19)20)15-5-3-2-4-6-15/h1-11,16H,12-15,17H2;1-9,14-15H,10-13,16H2;2*1-11,16H,12-15,17H2;2-13H,14H2,1H3
InChIKeyMLLADJZRRWILCU-UHFFFAOYSA-N
MW1882.10 g/mol
LogP22.45
Rot. Bonds20

About 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine

2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine (PubChem CID 159600688) has the molecular formula C114H104Cl2FN17O5 and a molecular weight of 1882.10 g/mol. Its IUPAC name is 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine.

Molecular Properties

Compound Name2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine
PubChem CID159600688
Molecular FormulaC114H104Cl2FN17O5
Molecular Weight1882.10 g/mol
Exact Mass1879.78
IUPAC Name2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine
SMILESCOCc1c(-c2ccc(Cl)cc2)nc2ccc(-c3ccccc3)cn12.Clc1ccc(-c2nc3cnc(-c4ccccc4)cn3c2CN2CCOCC2)cc1.Fc1ccc(-c2nc3ccc(-c4ccccc4)cn3c2CN2CCOCC2)cc1.c1ccc(-c2ccc3nc(-c4ccccn4)c(CN4CCOCC4)n3c2)cc1.c1ccc(-c2ccc3nc(-c4ccncc4)c(CN4CCOCC4)n3c2)cc1
InChIInChI=1S/C24H22FN3O.C23H21ClN4O.2C23H22N4O.C21H17ClN2O/c25-21-9-6-19(7-10-21)24-22(17-27-12-14-29-15-13-27)28-16-20(8-11-23(28)26-24)18-4-2-1-3-5-18;24-19-8-6-18(7-9-19)23-21(16-27-10-12-29-13-11-27)28-15-20(25-14-22(28)26-23)17-4-2-1-3-5-17;1-2-6-18(7-3-1)19-9-10-22-25-23(20-8-4-5-11-24-20)21(27(22)16-19)17-26-12-14-28-15-13-26;1-2-4-18(5-3-1)20-6-7-22-25-23(19-8-10-24-11-9-19)21(27(22)16-20)17-26-12-14-28-15-13-26;1-25-14-19-21(16-7-10-18(22)11-8-16)23-20-12-9-17(13-24(19)20)15-5-3-2-4-6-15/h1-11,16H,12-15,17H2;1-9,14-15H,10-13,16H2;2*1-11,16H,12-15,17H2;2-13H,14H2,1H3
InChIKeyMLLADJZRRWILCU-UHFFFAOYSA-N
XLogP22.45
TPSA184.28 Ų
H-Bond Donors
H-Bond Acceptors22
Rotatable Bonds20
Heavy Atoms139
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001882.10
LogP ≤ 522.45
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1022

Analyze 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?
The IUPAC name of 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine (CID 159600688) is 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine.
What is the SMILES notation for 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?
The canonical SMILES for 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine is COCc1c(-c2ccc(Cl)cc2)nc2ccc(-c3ccccc3)cn12.Clc1ccc(-c2nc3cnc(-c4ccccc4)cn3c2CN2CCOCC2)cc1.Fc1ccc(-c2nc3ccc(-c4ccccc4)cn3c2CN2CCOCC2)cc1.c1ccc(-c2ccc3nc(-c4ccccn4)c(CN4CCOCC4)n3c2)cc1.c1ccc(-c2ccc3nc(-c4ccncc4)c(CN4CCOCC4)n3c2)cc1.
What is the InChIKey of 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?
The InChIKey is MLLADJZRRWILCU-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H22FN3O.C23H21ClN4O.2C23H22N4O.C21H17ClN2O/c25-21-9-6-19(7-10-21)24-22(17-27-12-14-29-15-13-27)28-16-20(8-11-23(28)26-24)18-4-2-1-3-5-18;24-19-8-6-18(7-9-19)23-21(16-27-10-12-29-13-11-27)28-15-20(25-14-22(28)26-23)17-4-2-1-3-5-17;1-2-6-18(7-3-1)19-9-10-22-25-23(20-8-4-5-11-24-20)21(27(22)16-19)17-26-12-14-28-15-13-26;1-2-4-18(5-3-1)20-6-7-22-25-23(19-8-10-24-11-9-19)21(27(22)16-20)17-26-12-14-28-15-13-26;1-25-14-19-21(16-7-10-18(22)11-8-16)23-20-12-9-17(13-24(19)20)15-5-3-2-4-6-15/h1-11,16H,12-15,17H2;1-9,14-15H,10-13,16H2;2*1-11,16H,12-15,17H2;2-13H,14H2,1H3.
What are the key properties of 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine?
2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine has a molecular weight of 1882.10 g/mol, XLogP of 22.45, 20 rotatable bonds, 0 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-chlorophenyl)-3-(methoxymethyl)-6-phenylimidazo[1,2-a]pyridine;4-[[2-(4-chlorophenyl)-6-phenylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-fluorophenyl)-6-phenylimidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[(6-phenyl-2-pyridin-2-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine;4-[(6-phenyl-2-pyridin-4-ylimidazo[1,2-a]pyridin-3-yl)methyl]morpholine is sourced from PubChem (CID 159600688), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).